| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | positive regulation of early endosome to late endosome transport | 2.77e-05 | 9 | 145 | 3 | GO:2000643 | |
| GeneOntologyBiologicalProcess | regulation of protein localization to early endosome | 3.94e-05 | 10 | 145 | 3 | GO:1902965 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization to early endosome | 3.94e-05 | 10 | 145 | 3 | GO:1902966 | |
| Domain | NPIP | 5.71e-08 | 14 | 149 | 5 | IPR009443 | |
| Domain | ERM_C_dom | 1.98e-06 | 4 | 149 | 3 | IPR011259 | |
| Domain | ERM | 1.98e-06 | 4 | 149 | 3 | PF00769 | |
| Domain | ERM | 1.98e-06 | 4 | 149 | 3 | IPR011174 | |
| Domain | Moesin_tail | 1.70e-05 | 7 | 149 | 3 | IPR008954 | |
| Domain | DH_1 | 1.46e-04 | 63 | 149 | 5 | PS00741 | |
| Domain | REELIN | 1.89e-04 | 3 | 149 | 2 | PS51019 | |
| Domain | Reeler_dom | 1.89e-04 | 3 | 149 | 2 | IPR002861 | |
| Domain | Reeler | 1.89e-04 | 3 | 149 | 2 | PF02014 | |
| Domain | RhoGEF | 2.10e-04 | 68 | 149 | 5 | SM00325 | |
| Domain | RhoGEF | 2.41e-04 | 70 | 149 | 5 | PF00621 | |
| Domain | DH_2 | 2.41e-04 | 70 | 149 | 5 | PS50010 | |
| Domain | - | 2.58e-04 | 71 | 149 | 5 | 1.20.900.10 | |
| Domain | DH-domain | 2.58e-04 | 71 | 149 | 5 | IPR000219 | |
| Domain | PINIT | 3.75e-04 | 4 | 149 | 2 | PS51466 | |
| Domain | PINIT | 3.75e-04 | 4 | 149 | 2 | PF14324 | |
| Domain | Aldehyde_DH_NAD(P) | 3.75e-04 | 4 | 149 | 2 | IPR012394 | |
| Domain | PINIT | 3.75e-04 | 4 | 149 | 2 | IPR023321 | |
| Domain | - | 4.39e-04 | 19 | 149 | 3 | 3.40.605.10 | |
| Domain | Aldedh | 4.39e-04 | 19 | 149 | 3 | PF00171 | |
| Domain | Ald_DH_C | 4.39e-04 | 19 | 149 | 3 | IPR016163 | |
| Domain | Ald_DH_N | 4.39e-04 | 19 | 149 | 3 | IPR016162 | |
| Domain | Ald_DH/histidinol_DH | 4.39e-04 | 19 | 149 | 3 | IPR016161 | |
| Domain | Aldehyde_DH_dom | 4.39e-04 | 19 | 149 | 3 | IPR015590 | |
| Domain | - | 4.39e-04 | 19 | 149 | 3 | 3.40.309.10 | |
| Domain | Ez/rad/moesin-like | 5.96e-04 | 21 | 149 | 3 | IPR000798 | |
| Domain | FERM_CS | 8.91e-04 | 24 | 149 | 3 | IPR019747 | |
| Domain | FERM_C | 1.13e-03 | 26 | 149 | 3 | PF09380 | |
| Domain | FERM_PH-like_C | 1.26e-03 | 27 | 149 | 3 | IPR018980 | |
| Domain | Endo/exonuclease/phosphatase | 1.26e-03 | 27 | 149 | 3 | IPR005135 | |
| Domain | FERM_C | 1.26e-03 | 27 | 149 | 3 | SM01196 | |
| Domain | zf-MIZ | 1.29e-03 | 7 | 149 | 2 | PF02891 | |
| Domain | ZF_SP_RING | 1.29e-03 | 7 | 149 | 2 | PS51044 | |
| Domain | GDA1_CD39_NTPase | 1.72e-03 | 8 | 149 | 2 | IPR000407 | |
| Domain | Enoyl-CoA_hyd/isom_CS | 1.72e-03 | 8 | 149 | 2 | IPR018376 | |
| Domain | Znf_MIZ | 1.72e-03 | 8 | 149 | 2 | IPR004181 | |
| Domain | GDA1_CD39 | 1.72e-03 | 8 | 149 | 2 | PF01150 | |
| Domain | GDA1_CD39_NTPASE | 1.72e-03 | 8 | 149 | 2 | PS01238 | |
| Pathway | WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY | 2.35e-06 | 12 | 120 | 4 | M45558 | |
| Pubmed | Novel retinal and cone photoreceptor transcripts revealed by human macular expression profiling. | 3.70e-10 | 4 | 154 | 4 | 18055785 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | FLII ABCC3 NLRX1 MAEA RTTN C15orf39 LHPP FRYL CEP192 GRIN2D SPPL2B NOD2 VOPP1 C2CD3 MTMR14 INF2 CD2BP2 DISP2 SPEN GCN1 PREX1 | 2.14e-08 | 1105 | 154 | 21 | 35748872 |
| Pubmed | Finding the Unicorn, a New Mouse Model of Midfacial Clefting. | 4.58e-08 | 9 | 154 | 4 | 31940751 | |
| Pubmed | Radixin regulates cell migration and cell-cell adhesion through Rac1. | 4.58e-08 | 9 | 154 | 4 | 22467863 | |
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 8479753 | ||
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 18261459 | ||
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 21659656 | ||
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 19064715 | ||
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 21864676 | ||
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 14613898 | ||
| Pubmed | Inhibition of cell adhesion by phosphorylated Ezrin/Radixin/Moesin. | 8.51e-08 | 3 | 154 | 3 | 26555866 | |
| Pubmed | Human ezrin-moesin-radixin proteins modulate hepatitis C virus infection. | 8.51e-08 | 3 | 154 | 3 | 23703860 | |
| Pubmed | Pseudomonas aeruginosa ExoS ADP-ribosyltransferase inhibits ERM phosphorylation. | 8.51e-08 | 3 | 154 | 3 | 16889625 | |
| Pubmed | Effect of knockdown of ezrin, radixin, and moesin on P-glycoprotein function in HepG2 cells. | 8.51e-08 | 3 | 154 | 3 | 21837648 | |
| Pubmed | Ezrin and moesin function together to promote T cell activation. | 8.51e-08 | 3 | 154 | 3 | 19124745 | |
| Pubmed | Activation of Ras requires the ERM-dependent link of actin to the plasma membrane. | 8.51e-08 | 3 | 154 | 3 | 22132106 | |
| Pubmed | Ezrin-radixin-moesin family proteins are involved in parvovirus replication and spreading. | 8.51e-08 | 3 | 154 | 3 | 19321616 | |
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 29906485 | ||
| Pubmed | Activation of PKC induces leukocyte adhesion by the dephosphorylation of ERM. | 8.51e-08 | 3 | 154 | 3 | 31843195 | |
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 21278069 | ||
| Pubmed | Nuclear ERM (ezrin, radixin, moesin) proteins: regulation by cell density and nuclear import. | 8.51e-08 | 3 | 154 | 3 | 15149851 | |
| Pubmed | ERM stable knockdown by siRNA reduced in vitro migration and invasion of human SGC-7901 cells. | 8.51e-08 | 3 | 154 | 3 | 21352885 | |
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 1429901 | ||
| Pubmed | ERM Proteins at the Crossroad of Leukocyte Polarization, Migration and Intercellular Adhesion. | 8.51e-08 | 3 | 154 | 3 | 32098334 | |
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 18295815 | ||
| Pubmed | Dmoesin controls actin-based cell shape and polarity during Drosophila melanogaster oogenesis. | 8.51e-08 | 3 | 154 | 3 | 12360288 | |
| Pubmed | Dynamics and function of ERM proteins during cytokinesis in human cells. | 8.51e-08 | 3 | 154 | 3 | 28889652 | |
| Pubmed | Control of adipogenesis by ezrin, radixin and moesin-dependent biomechanics remodeling. | 8.51e-08 | 3 | 154 | 3 | 23116763 | |
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 21451358 | ||
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 20679347 | ||
| Pubmed | Differential expression and distribution of ezrin, radixin and moesin in human natural killer cells. | 8.51e-08 | 3 | 154 | 3 | 12385025 | |
| Pubmed | Are ERM (ezrin/radixin/moesin) proteins targets for autoantibodies in demyelinating neuropathies? | 8.51e-08 | 3 | 154 | 3 | 25286001 | |
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 17977945 | ||
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 15252013 | ||
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 32160548 | ||
| Pubmed | 8.51e-08 | 3 | 154 | 3 | 12734202 | ||
| Pubmed | 1.78e-07 | 12 | 154 | 4 | 29361573 | ||
| Pubmed | CPI-17 drives oncogenic Ras signaling in human melanomas via Ezrin-Radixin-Moesin family proteins. | 3.39e-07 | 4 | 154 | 3 | 27793041 | |
| Pubmed | 3.39e-07 | 4 | 154 | 3 | 15096511 | ||
| Pubmed | 3.39e-07 | 4 | 154 | 3 | 17237445 | ||
| Pubmed | 3.39e-07 | 4 | 154 | 3 | 15178693 | ||
| Pubmed | 3.39e-07 | 4 | 154 | 3 | 20660156 | ||
| Pubmed | 3.39e-07 | 4 | 154 | 3 | 19129194 | ||
| Pubmed | 3.39e-07 | 4 | 154 | 3 | 31018575 | ||
| Pubmed | 3.39e-07 | 4 | 154 | 3 | 24760896 | ||
| Pubmed | Spatial regulation of cyclic AMP-Epac1 signaling in cell adhesion by ERM proteins. | 3.39e-07 | 4 | 154 | 3 | 20855527 | |
| Pubmed | Functional binding interaction identified between the axonal CAM L1 and members of the ERM family. | 3.39e-07 | 4 | 154 | 3 | 12070130 | |
| Pubmed | 3.39e-07 | 4 | 154 | 3 | 19890007 | ||
| Pubmed | 3.39e-07 | 4 | 154 | 3 | 28302370 | ||
| Pubmed | 3.39e-07 | 4 | 154 | 3 | 22685202 | ||
| Pubmed | 3.39e-07 | 4 | 154 | 3 | 26887924 | ||
| Pubmed | 3.39e-07 | 4 | 154 | 3 | 21289089 | ||
| Pubmed | The ERM proteins interact with the HOPS complex to regulate the maturation of endosomes. | 3.39e-07 | 4 | 154 | 3 | 21148287 | |
| Pubmed | 3.39e-07 | 4 | 154 | 3 | 18941185 | ||
| Pubmed | 3.39e-07 | 4 | 154 | 3 | 15818415 | ||
| Pubmed | Proteomic profiling in pancreatic cancer with and without lymph node metastasis. | 3.39e-07 | 4 | 154 | 3 | 19152423 | |
| Pubmed | 3.39e-07 | 4 | 154 | 3 | 19255442 | ||
| Pubmed | 3.39e-07 | 4 | 154 | 3 | 9890997 | ||
| Pubmed | 8.46e-07 | 5 | 154 | 3 | 9464455 | ||
| Pubmed | Activated ERM protein plays a critical role in drug resistance of MOLT4 cells induced by CCL25. | 8.46e-07 | 5 | 154 | 3 | 23326330 | |
| Pubmed | 8.46e-07 | 5 | 154 | 3 | 19830727 | ||
| Pubmed | A Pak1-PP2A-ERM signaling axis mediates F-actin rearrangement and degranulation in mast cells. | 8.46e-07 | 5 | 154 | 3 | 23063725 | |
| Pubmed | 8.46e-07 | 5 | 154 | 3 | 21278261 | ||
| Pubmed | 8.46e-07 | 5 | 154 | 3 | 22891241 | ||
| Pubmed | The TSC1 tumour suppressor hamartin regulates cell adhesion through ERM proteins and the GTPase Rho. | 8.46e-07 | 5 | 154 | 3 | 10806479 | |
| Pubmed | 8.46e-07 | 5 | 154 | 3 | 23019340 | ||
| Pubmed | 8.46e-07 | 5 | 154 | 3 | 25575591 | ||
| Pubmed | A novel role for BRCA1 in regulating breast cancer cell spreading and motility. | 8.46e-07 | 5 | 154 | 3 | 21282464 | |
| Pubmed | VANGL2 regulates luminal epithelial organization and cell turnover in the mammary gland. | 1.08e-06 | 18 | 154 | 4 | 31068622 | |
| Pubmed | 1.36e-06 | 19 | 154 | 4 | 17507402 | ||
| Pubmed | 1.69e-06 | 6 | 154 | 3 | 17515952 | ||
| Pubmed | 1.69e-06 | 6 | 154 | 3 | 23229862 | ||
| Pubmed | 1.69e-06 | 6 | 154 | 3 | 9472040 | ||
| Pubmed | 1.69e-06 | 6 | 154 | 3 | 17349711 | ||
| Pubmed | 1.69e-06 | 6 | 154 | 3 | 26209696 | ||
| Pubmed | 2.94e-06 | 7 | 154 | 3 | 22291017 | ||
| Pubmed | MYADM controls endothelial barrier function through ERM-dependent regulation of ICAM-1 expression. | 2.94e-06 | 7 | 154 | 3 | 23264465 | |
| Pubmed | 3.67e-06 | 24 | 154 | 4 | 27217206 | ||
| Pubmed | 4.69e-06 | 8 | 154 | 3 | 24788249 | ||
| Pubmed | 1.21e-05 | 32 | 154 | 4 | 26184908 | ||
| Pubmed | 1.74e-05 | 35 | 154 | 4 | 32179912 | ||
| Pubmed | Alpha6beta4 integrin and dystroglycan cooperate to stabilize the myelin sheath. | 1.82e-05 | 12 | 154 | 3 | 18579745 | |
| Pubmed | LEO1 RNF213 RCC1 CEP192 STAM ZNF512B C2CD3 NCAPG TIAM1 MTMR14 PTPRR CD2BP2 MKI67 ALDH18A1 ATP2A2 GCN1 | 1.83e-05 | 1049 | 154 | 16 | 27880917 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 25299115 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 38417578 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 12111362 | ||
| Pubmed | Perspectives for Ezrin and Radixin in Astrocytes: Kinases, Functions and Pathology. | 1.95e-05 | 2 | 154 | 2 | 31382374 | |
| Pubmed | Expression of ezrin and moesin in primary breast carcinoma and matched lymph node metastases. | 1.95e-05 | 2 | 154 | 2 | 28624994 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 24737472 | ||
| Pubmed | Immunohistochemical assessment of ezrin and moesin in colorectal carcinoma. | 1.95e-05 | 2 | 154 | 2 | 27042764 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 22570716 | ||
| Pubmed | Moesin: a member of the protein 4.1-talin-ezrin family of proteins. | 1.95e-05 | 2 | 154 | 2 | 1924289 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 9213396 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 7579708 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 17204408 | ||
| Pubmed | Positive selection of a gene family during the emergence of humans and African apes. | 1.95e-05 | 2 | 154 | 2 | 11586358 | |
| Pubmed | Ezrin has properties to self-associate at the plasma membrane. | 1.95e-05 | 2 | 154 | 2 | 7844168 | |
| Pubmed | Emerging role for ERM proteins in cell adhesion and migration. | 1.95e-05 | 2 | 154 | 2 | 21343695 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 33206579 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 1955455 | ||
| Cytoband | 16p13.11 | 1.03e-06 | 23 | 154 | 4 | 16p13.11 | |
| Cytoband | 4p11 | 4.94e-04 | 10 | 154 | 2 | 4p11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16p13 | 6.22e-04 | 426 | 154 | 7 | chr16p13 | |
| GeneFamily | Aldehyde dehydrogenases | 1.20e-04 | 19 | 93 | 3 | 398 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 3.44e-04 | 181 | 93 | 6 | 694 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 3.71e-04 | 66 | 93 | 4 | 722 | |
| GeneFamily | Zinc fingers MIZ-type | 5.41e-04 | 7 | 93 | 2 | 85 | |
| GeneFamily | HAD Asp-based non-protein phosphatases | 1.40e-03 | 11 | 93 | 2 | 1045 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 2.17e-03 | 50 | 93 | 3 | 1293 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 4.23e-03 | 206 | 93 | 5 | 682 | |
| GeneFamily | Polypeptide N-acetylgalactosaminyltransferases | 4.68e-03 | 20 | 93 | 2 | 433 | |
| Coexpression | GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_40H_TSST_ACT_DN | 2.24e-06 | 197 | 151 | 9 | M5322 | |
| Coexpression | GSE34156_UNTREATED_VS_6H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN | 8.30e-06 | 175 | 151 | 8 | M8667 | |
| ToppCell | normal-na-Lymphocytic_B-B_plasma|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.88e-08 | 189 | 152 | 9 | 659deb617a560bcde67c75f477d30ce85aaec3c6 | |
| ToppCell | normal-na-Lymphocytic_B-B_plasma-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.88e-08 | 189 | 152 | 9 | 67f9a9861d2dcc128b7a69432c6b31da185e2249 | |
| ToppCell | Multiple_Sclerosis-Lymphocyte-B-Plasmablast|Multiple_Sclerosis / Disease, Lineage and Cell Type | 1.55e-07 | 174 | 152 | 8 | e8d2aa9505817aac3fe068080774d19458f07b01 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-B_plasma-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.92e-07 | 189 | 152 | 8 | 59e6fec454de621119571d4a8ec48be3bf02a32e | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-B_plasma|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.92e-07 | 189 | 152 | 8 | 43f25fb7257eab05df921ffcd5a6e49c78a03e3a | |
| ToppCell | MS-Multiple_Sclerosis-Lymphocyte-B-Plasmablast|Multiple_Sclerosis / Disease, condition lineage and cell class | 4.16e-07 | 198 | 152 | 8 | c30b71b998acde080adb90a2016a165c5ed17a81 | |
| ToppCell | Healthy_donor-Plasmablast|Healthy_donor / disease group, cell group and cell class (v2) | 2.69e-06 | 178 | 152 | 7 | 388b8b4fa20dcc6e9ae4b06118e20b2c20c52bde | |
| ToppCell | droplet-Heart-4Chambers-18m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-06 | 182 | 152 | 7 | 6fdaf3c8c3952a8f14dd7288e523ed58eb1d3517 | |
| ToppCell | 368C-Myeloid-Dendritic-cDC_proliferating_1|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.60e-06 | 186 | 152 | 7 | 799903b68bc6f6205d004b44c603424b0d5f7c32 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-plasmablast|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.86e-06 | 188 | 152 | 7 | 8cf135da4d1d2500755d2809d60b41509af9fa8b | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_VISp_Col6a1_Fezf2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.94e-06 | 122 | 152 | 6 | e96aec5af0ed1d8f4cc99fde59dd6998bbc1acbd | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-9|TCGA-Liver / Sample_Type by Project: Shred V9 | 1.20e-05 | 148 | 152 | 6 | 683b2b80ee389469d948aaf6a77632b24f56e989 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_ALM_Cpa6|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.50e-05 | 154 | 152 | 6 | 12cbc38bc1f7231c67e1d2d5e86e95bc12e24682 | |
| ToppCell | Int-URO-Lymphocyte-B-Plasmablast|Int-URO / Disease, Lineage and Cell Type | 1.80e-05 | 159 | 152 | 6 | f6ad73b6a3681471efbd4fafd9eb631764c53500 | |
| ToppCell | IIF-Lymphocyte-B-Plasmablast|IIF / Disease, Lineage and Cell Type | 1.93e-05 | 161 | 152 | 6 | 4d78985e7b11e92591e75a4864fd769882db2d1c | |
| ToppCell | droplet-Fat-Gat-18m-Hematologic|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-05 | 164 | 152 | 6 | 7dbe34a98a3b475c1ba678db8a5494c0c6a91e2d | |
| ToppCell | droplet-Fat-Gat-18m-Hematologic-erythroblast|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-05 | 164 | 152 | 6 | febcb8f8b305aa94e21131fa83d2890f7a6838fc | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.17e-05 | 98 | 152 | 5 | ffe21b3681fdeaf4a8447bd2b13772d03cdd45aa | |
| ToppCell | droplet-Fat-Gat-18m-Hematologic-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-05 | 165 | 152 | 6 | 1e89154114327650df39befb2c56d0379ea6a221 | |
| ToppCell | mild_COVID-19_(asymptomatic)-Plasmablast|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 2.29e-05 | 166 | 152 | 6 | 0cc3b9681bc000a1b00d3b60f79f16eea1c2e2e1 | |
| ToppCell | 343B-Myeloid-Dendritic-cDC_proliferating_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.37e-05 | 167 | 152 | 6 | 3461d14e36f09ddc6ee5549ca4797e16d3f37fcc | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Col23a1_Adamts2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.45e-05 | 168 | 152 | 6 | 3fe432267656aff81b6d92c18d1b6fc0cde73d6a | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-05 | 170 | 152 | 6 | ece7c20e89c190a7ec68032b6c2efeb458c43f9a | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.08e-05 | 175 | 152 | 6 | a6913f992a1ea20b43e5adeca3ede3a6fda820ad | |
| ToppCell | Nasal_Brush-Epithelial-Basal_2|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.18e-05 | 176 | 152 | 6 | fc5787946f5a10056d326d070620575ae4081836 | |
| ToppCell | Nasal_Brush-Epithelial-Basal_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.18e-05 | 176 | 152 | 6 | 5daaba0853afe7d20d4635169ccd4f96e735b938 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_B-plasmablast-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.28e-05 | 177 | 152 | 6 | d2c1f46913ac00bbc0bb9320d5652edc01b34179 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_B-plasmablast|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.28e-05 | 177 | 152 | 6 | 65e090aad0ffb737ce034e25bd5b12a0b1dd9684 | |
| ToppCell | 368C-Myeloid-Dendritic-cDC_proliferating_1|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.50e-05 | 179 | 152 | 6 | ec69e1dd897414033ba5b007aa82655a79adca6c | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.61e-05 | 180 | 152 | 6 | 9db9899ca42455310e9b63df523fe6c4780abfb7 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.72e-05 | 181 | 152 | 6 | 9c157de9d3403e092c907599f2a2c16db5b21131 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.72e-05 | 181 | 152 | 6 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.72e-05 | 181 | 152 | 6 | eea943fdcbef0bbaa8578f3296923e874893b405 | |
| ToppCell | droplet-Liver-Npc-21m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.84e-05 | 182 | 152 | 6 | dc55de945c6f78f32eb3a1b3520835eb8417e068 | |
| ToppCell | droplet-Liver-Npc-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.84e-05 | 182 | 152 | 6 | 010a7364da46101cb5068891fd7bc712ea8f13bd | |
| ToppCell | droplet-Liver-Npc-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.84e-05 | 182 | 152 | 6 | b1ec2015aad1181eac1bbf8d48ad6f2f7ed24a01 | |
| ToppCell | Control-T/NK-proliferating_T/NK|Control / Disease group,lineage and cell class (2021.01.30) | 3.95e-05 | 183 | 152 | 6 | e740f05536d1e4b2512811771928eb65f6696409 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.95e-05 | 183 | 152 | 6 | bc7dd6a40ec9c773d005c1a46f305d40cdd0a326 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.08e-05 | 184 | 152 | 6 | a0831e850bc0b585296ed350fdd075c1f730308e | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.20e-05 | 185 | 152 | 6 | ca69499ba8c39b7ed6717d05685d6f70066a77bd | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_T_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.20e-05 | 185 | 152 | 6 | 9d424a8608b339dd6129c58d87626678d4ec4af7 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.33e-05 | 186 | 152 | 6 | 4bb54043f944a979db91bde9a86dd66f498c7658 | |
| ToppCell | 368C-Myeloid-Dendritic-cDC_proliferating_1|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 4.33e-05 | 186 | 152 | 6 | 5cadab3271fce9ab6da3d7ba9827b8a221cac166 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-B_plasma|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.46e-05 | 187 | 152 | 6 | 88d20f150df61ef0e3ee0c3e9895b094920c4b09 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-B_plasma-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.46e-05 | 187 | 152 | 6 | 158c2c003fd225ba61793fb06eece232fb063d05 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.60e-05 | 188 | 152 | 6 | 7471c194276161422326647f09022e94f3d1640c | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-plasmablast-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.60e-05 | 188 | 152 | 6 | ecba5d06cbf3254448255a2aeefffe711f43310e | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B_plasma-Plasmablasts|bone_marrow / Manually curated celltypes from each tissue | 4.60e-05 | 188 | 152 | 6 | 4caae2acd9ec0eb79b7476a1e59f30f39afddcda | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.60e-05 | 188 | 152 | 6 | 053c251d3ddbeb866f34565aefca4535517b4387 | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Dendritic-Cycling_Dendritic|lymph-node_spleen / Manually curated celltypes from each tissue | 4.60e-05 | 188 | 152 | 6 | 723348a1836a074e068320cb736ce6a953e0038f | |
| ToppCell | droplet-Lung-immune-endo-depleted|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.73e-05 | 189 | 152 | 6 | c3fb363bb0156ffb3367c200f548faebda64ab4a | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.73e-05 | 189 | 152 | 6 | 2a2953f6b1b7d070d739dcaf7285fce6e097d9e4 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.73e-05 | 189 | 152 | 6 | fd8834d1feb7f63911c5fa51efb1f679a8baddeb | |
| ToppCell | PBMC-Mild-cDC_12|Mild / Compartment, Disease Groups and Clusters | 4.73e-05 | 189 | 152 | 6 | 946c95d2ecc36b241f58e8c4ad6455fe47c762fa | |
| ToppCell | droplet-Heart-nan-24m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.73e-05 | 189 | 152 | 6 | 1137583e21d874c201c20581ba1995e2bfa3de59 | |
| ToppCell | droplet-Lung-3m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.73e-05 | 189 | 152 | 6 | 5a636e952da9b1fd26aa17f7b129054f2da322b5 | |
| ToppCell | droplet-Heart-nan-24m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.87e-05 | 190 | 152 | 6 | 7068754c29f63a331e2b6c54715f3b26f37ad32b | |
| ToppCell | droplet-Bladder|droplet / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.87e-05 | 190 | 152 | 6 | 170484f7a6f0a0d0792bbe1bb04abad060b7188e | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.87e-05 | 190 | 152 | 6 | 9cd147a174017ebda23cc47b6d4552d898acd092 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.02e-05 | 191 | 152 | 6 | ce80f65bd24b1c4d2152bf45248449e7a1a97e56 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.02e-05 | 191 | 152 | 6 | ece87127f85939e61b1048d968ed96f0e87c3a79 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.02e-05 | 191 | 152 | 6 | 478e8341ee03b05501e2233e02cef5f97492c95d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-Plasma_cell|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.17e-05 | 192 | 152 | 6 | ec279980602292fc8ed6362edd36a5c772d59777 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.17e-05 | 192 | 152 | 6 | df1545670370fb1010c567cd059c2783eab315f7 | |
| ToppCell | facs-Lung-3m-Mesenchymal|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.17e-05 | 192 | 152 | 6 | 8df15085b35b86f39debd933284cb703c5dd63c2 | |
| ToppCell | facs-Lung-EPCAM-18m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.17e-05 | 192 | 152 | 6 | 5876ff75e273a48e7ad8236423fb41e4ae4c0a91 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-H_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.30e-05 | 118 | 152 | 5 | 08bdf7bc3c9dcbc0f690658fe14e6cc4b9581698 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-H_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.30e-05 | 118 | 152 | 5 | 3b077ad5c68c01b3fcc93f203cb130bb90705af9 | |
| ToppCell | Severe_COVID-19-Myeloid-proliferating_Myeloid_cells|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 5.32e-05 | 193 | 152 | 6 | 0d85025690c9cd545cba30abc38acbdd6a39b153 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 5.32e-05 | 193 | 152 | 6 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.47e-05 | 194 | 152 | 6 | cb39850e9577015b6b9834e98c36b412bae7d462 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.47e-05 | 194 | 152 | 6 | 408597c9aa302a44b112c1d612c21fbb0227a82a | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.47e-05 | 194 | 152 | 6 | 193cc20fefbd795a4ad59e401a95af47d30603e7 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.47e-05 | 194 | 152 | 6 | 2360b5f995b360419de41612368cab9fb61781a1 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.47e-05 | 194 | 152 | 6 | 903ae11708b0cb24538c6982abd57fe6fa95b8d3 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.47e-05 | 194 | 152 | 6 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.47e-05 | 194 | 152 | 6 | 58406502a8cbcc3037f79a1b6a683df408297ae5 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-H_(AT1)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.47e-05 | 194 | 152 | 6 | 4c40d6b50675eae52c419d69e719a9223df02ae3 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-H_(AT1)|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.47e-05 | 194 | 152 | 6 | 99a90de637e3babec2131cdd9f05ea965d8a8f30 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c06-MKI67|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.47e-05 | 194 | 152 | 6 | 5771a28a61f4d9b5479891f3224909ab003cb241 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac2_Tacstd2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.52e-05 | 119 | 152 | 5 | e868453c02dcf0e07821886b81ca739887d43c67 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.63e-05 | 195 | 152 | 6 | cec7df321f372d05c94f97d6bb18891a5cc3dec3 | |
| ToppCell | ASK428-Mesenchymal|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 5.63e-05 | 195 | 152 | 6 | 2b156163975d9a3d3fda1402acd9831d0fdc9e25 | |
| ToppCell | Healthy/Control-T/NK_proliferative|Healthy/Control / Disease group and Cell class | 5.63e-05 | 195 | 152 | 6 | 957458fdc39723f4a31bd7fd3ce32891aa3fd462 | |
| ToppCell | ASK428-Mesenchymal-Fibroblast|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 5.63e-05 | 195 | 152 | 6 | c269c0d894a0f55da6495b59d4b9abb9f68df684 | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-B-Plasmablast|Int-URO / Disease, condition lineage and cell class | 5.79e-05 | 196 | 152 | 6 | e65b47d0ce1a5dd05f5f50e1639c8ec76fb42dc8 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.79e-05 | 196 | 152 | 6 | 7d5eaed189aa6116f3799be010139fb675ec65e0 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.79e-05 | 196 | 152 | 6 | df366d76ea55f49e349d622effa57c1535df8400 | |
| ToppCell | LPS_IL1RA_TNF|World / Treatment groups by lineage, cell group, cell type | 5.96e-05 | 197 | 152 | 6 | 0a6550dce156fc81f15b1e7830d331ca50d87d06 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.96e-05 | 197 | 152 | 6 | 1d4ccca2ff46fccb3ac052b5148cb7f94231d65a | |
| ToppCell | MS-IIF-Lymphocyte-B-Plasmablast|IIF / Disease, condition lineage and cell class | 5.96e-05 | 197 | 152 | 6 | 1b5ac53297cc557e08b9e8e511c2385a38f56bd6 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c10-MKI67-GZMK|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.96e-05 | 197 | 152 | 6 | 17bd2aef8d8792703973643ec9743efd546b7b69 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK_activated|Control / Disease, condition lineage and cell class | 6.13e-05 | 198 | 152 | 6 | 76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7 | |
| ToppCell | TCGA-Lung-Primary_Tumor|TCGA-Lung / Sample_Type by Project: Shred V9 | 6.30e-05 | 199 | 152 | 6 | d1d035e987280607266171094db5d6362efe1ad5 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.30e-05 | 199 | 152 | 6 | 92fdf6e2f0786ab2ab78126e9131a93794168139 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma|TCGA-Lung / Sample_Type by Project: Shred V9 | 6.30e-05 | 199 | 152 | 6 | 6748d4f76703360071d5f2026d9d06bf30ccfb6d | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.48e-05 | 200 | 152 | 6 | 6e3d1ae0ef84d3075afa40129a41169996462672 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c10-MKI67-GZMK|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.48e-05 | 200 | 152 | 6 | 562309f9ca4a73cea5ed1d85b516891545f3ae5f | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 6.48e-05 | 200 | 152 | 6 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.48e-05 | 200 | 152 | 6 | 54806080b5e97859ee6a4a9b4f19e22021c218f5 | |
| Disease | Autosomal dominant epilepsy with auditory features | 7.17e-05 | 3 | 145 | 2 | cv:C1838062 | |
| Disease | EPILEPSY, FAMILIAL TEMPORAL LOBE, 1 | 7.17e-05 | 3 | 145 | 2 | 600512 | |
| Disease | Epilepsy, Familial Temporal Lobe 1 | 7.17e-05 | 3 | 145 | 2 | C4551957 | |
| Disease | Epilepsy, familial temporal lobe, 1 | 7.17e-05 | 3 | 145 | 2 | cv:C4551957 | |
| Disease | mucositis (biomarker_via_orthology) | 2.38e-04 | 5 | 145 | 2 | DOID:0080178 (biomarker_via_orthology) | |
| Disease | Sjogren-Larsson syndrome (implicated_via_orthology) | 3.55e-04 | 6 | 145 | 2 | DOID:14501 (implicated_via_orthology) | |
| Disease | Abnormality of the eye | 4.96e-04 | 7 | 145 | 2 | C4316870 | |
| Disease | ascending aortic diameter | 6.55e-04 | 140 | 145 | 5 | EFO_0021787 | |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 8.16e-04 | 147 | 145 | 5 | DOID:9352 (biomarker_via_orthology) | |
| Disease | hyperprolactinemia (biomarker_via_orthology) | 8.44e-04 | 9 | 145 | 2 | DOID:12700 (biomarker_via_orthology) | |
| Disease | Barrett's esophagus (is_marker_for) | 1.28e-03 | 11 | 145 | 2 | DOID:9206 (is_marker_for) | |
| Disease | hematologic cancer (implicated_via_orthology) | 1.81e-03 | 13 | 145 | 2 | DOID:2531 (implicated_via_orthology) | |
| Disease | phosphatidylcholine 40:7 measurement | 1.81e-03 | 13 | 145 | 2 | EFO_0021477 | |
| Disease | glycochenodeoxycholate glucuronide (1) measurement | 1.81e-03 | 13 | 145 | 2 | EFO_0800474 | |
| Disease | antibody measurement | 1.81e-03 | 49 | 145 | 3 | EFO_0004556 | |
| Disease | disease recurrence, colon carcinoma | 2.04e-03 | 51 | 145 | 3 | EFO_0004952, EFO_1001950 | |
| Disease | Colorectal Carcinoma | 2.54e-03 | 702 | 145 | 10 | C0009402 | |
| Disease | response to efavirenz, virologic response measurement | 2.94e-03 | 58 | 145 | 3 | EFO_0006904, EFO_0006906 | |
| Disease | X-21441 measurement | 3.11e-03 | 17 | 145 | 2 | EFO_0800814 | |
| Disease | graft-versus-host disease (is_implicated_in) | 3.11e-03 | 17 | 145 | 2 | DOID:0081267 (is_implicated_in) | |
| Disease | Liver carcinoma | 3.69e-03 | 507 | 145 | 8 | C2239176 | |
| Disease | kidney disease (biomarker_via_orthology) | 4.74e-03 | 21 | 145 | 2 | DOID:557 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QRMPLLTSKLTLTCG | 156 | Q9BXU7 | |
| GKIPLNALTMCLARL | 331 | Q9BXU7 | |
| PMLAGCVARVAALKI | 671 | Q8N944 | |
| LGTGARMPCIKTRLQ | 771 | Q8NDL9 | |
| MRLQAHVLGQLKPVC | 366 | Q8NCV1 | |
| GLSLCPLRQMKRGVI | 66 | P61568 | |
| QAGALVQRLCMRTPI | 176 | Q6PL45 | |
| RACLLRSPGMEKLNA | 426 | P43353 | |
| RSCLVRPLMNDEGLK | 426 | P30838 | |
| RVTRLPLLMDTLCLK | 426 | Q5VV41 | |
| RRLMGLQKLCQPASV | 546 | Q8WXK1 | |
| LLLAAVMVACGLRPA | 711 | A5YM72 | |
| RVTRLPLLMDTICQK | 581 | Q96DR7 | |
| DRAINNRPCQILMGK | 211 | O60423 | |
| MVAGTRCLLALLLPQ | 1 | P12643 | |
| RLPAVRCLALFMGTA | 611 | A7MBM2 | |
| STGQPCILLKMNRIV | 241 | Q9UN42 | |
| CILLKMNRIVGFRPE | 246 | Q9UN42 | |
| LSRPMQRKLVTLVNC | 126 | Q9HBD1 | |
| RRLLQAPASACLLLM | 6 | Q86UN3 | |
| GRQGLERLLVPKCVM | 216 | P18754 | |
| LLIPLNGAVAVKMRA | 461 | O15438 | |
| MEVAANCSLRVKRPL | 1 | Q96RS6 | |
| SARKPLCNRVRMAAV | 206 | Q9UND3 | |
| RPRIIRCLMTHNKGV | 196 | Q5SQ64 | |
| GMKSILPIFRCLNSL | 86 | Q6WBX8 | |
| APRLRINKRILALCM | 271 | P35241 | |
| RRPVMLLCLMGVATS | 116 | Q14728 | |
| VITPKMLSGFLCRDR | 76 | Q8NGM9 | |
| MRQLKGRRVAACQPA | 1581 | M0R2J8 | |
| RCSKTQKIRILPMAG | 511 | Q8WVC0 | |
| PVRMAIIKKSGNNRC | 1116 | O00370 | |
| NMPLRGKQLRVRFAC | 131 | Q15233 | |
| LKLGQELCGMLHRPR | 801 | Q13045 | |
| VCSRSLNKLAQPLPM | 316 | Q7L5Y9 | |
| TLLLVMLTGAQRACP | 21 | Q86VH4 | |
| PLNLCVKIVQGIRAM | 256 | Q8TD19 | |
| ILCTAGMRLLPERKQ | 171 | Q9NQZ7 | |
| KMARCRGRFVCPVIL | 121 | Q8NCE2 | |
| LPLGQRQRLVKRMRC | 11 | Q9Y6X6 | |
| LDRIARNRKTIVCPM | 251 | Q86SR1 | |
| ICKLPGRVMGIRVLR | 6 | Q9UBQ6 | |
| MAALRVLLSCVRGPL | 1 | P30084 | |
| ALLKMRRQHPGCLAQ | 216 | Q08426 | |
| SVLIMNCRIGHPVLK | 901 | P38570 | |
| PDGKIMVRRCLVTLR | 6 | Q3V5L5 | |
| ACTGNPDLIMRARKT | 176 | Q32ZL2 | |
| MAAPTKCQLRGRLVL | 1 | Q9Y5G4 | |
| MGLPLARLAAVCLAL | 1 | Q02817 | |
| PENRTLIKRMLIKCA | 711 | O60658 | |
| RRTREKLMNVLSLCG | 2356 | O94915 | |
| GRPMLLSACRAGVIK | 1556 | O75037 | |
| AQRRGFVMLPRLCLK | 226 | A0A1B0GTW7 | |
| FVMLPRLCLKLLGSS | 231 | A0A1B0GTW7 | |
| MTAKKQCLLRLGVLR | 296 | Q8TDZ2 | |
| APRLRINKRILALCM | 271 | P26038 | |
| ACVMPSRLKALGTLV | 906 | Q92616 | |
| CGMRALQVRTGKFRP | 226 | Q9H008 | |
| LVLLVRILCGSRKMP | 196 | Q96LB0 | |
| ELLACRNLMPSAGKA | 1281 | P46013 | |
| LNLAGVRMTPVKCTV | 701 | Q86UT6 | |
| SARKPLCNRVRMAAA | 206 | F8WFD2 | |
| ARKPLCNRVRMAAAE | 226 | E9PIF3 | |
| LDMVRPKAQLVLAAC | 731 | Q27J81 | |
| CRLDKMIDLIIPRGS | 546 | P54886 | |
| MRRAVCFPALCLLLN | 1 | Q15256 | |
| SGMRPCDISRILKVS | 36 | O43316 | |
| MGPRRLLLVAACFSL | 1 | P25116 | |
| CLDVSRLNGPVIMLK | 481 | Q8IUC8 | |
| LITIGLRATRPAFMC | 61 | Q9NQV7 | |
| IGRALGRVAPSMLLC | 736 | Q9UHC9 | |
| RSGRQMLCDLLIKPH | 296 | Q3KR16 | |
| SCVGGMNRRPILIIV | 311 | Q9H3D4 | |
| TRERLAMRLKGLGCQ | 221 | O95400 | |
| GKRRPVIAFCLLMIL | 11 | Q9UFP1 | |
| VAMRRSGCLPLLLQI | 306 | O95996 | |
| KLCRQAGIRVIMITG | 611 | P16615 | |
| TKNRRCKLLPLVMAA | 481 | O75419 | |
| IRCKLSRIMFQLPAD | 3726 | Q4G0P3 | |
| ACKSLGRKILIPALM | 476 | P34913 | |
| CVEILSRAKRPLMVL | 276 | A1L0T0 | |
| VAKGTLPLSRICAMV | 1126 | Q4AC94 | |
| RICPILMEKLNRNSR | 66 | Q13609 | |
| MRAARALLPLLLQAC | 1 | P12109 | |
| LIMKTCFSPNRVIGL | 251 | O00303 | |
| MQCSFRRNITLPGVK | 301 | Q6ZNA5 | |
| PLQKHLRVCSLRMNR | 116 | Q9H0A8 | |
| PRRCATVAANKIKIM | 2231 | Q9NSI6 | |
| MNKVLGRSLPTCLPV | 421 | P48740 | |
| RSPCKMRLLGAAQSL | 36 | Q96QS3 | |
| PTRLSCMLARLEIKQ | 1846 | Q8TEP8 | |
| LLCQRMKLGSPVFLT | 261 | Q8IYX4 | |
| IPCRVGLFTLAMNRA | 86 | Q9BXC0 | |
| MLVLRCRLGTSFPKL | 1 | Q9NRM1 | |
| APRLRINKRILQLCM | 271 | P15311 | |
| CLTRGMKVLLRVGQS | 156 | Q15768 | |
| KGQASAMELLRCPTL | 321 | Q4U2R8 | |
| LPPQRRLIGKQCMCL | 581 | Q8NEC7 | |
| MCRIAGALRTLLPLL | 1 | P19022 | |
| AMLKHPNIIALRGVC | 196 | P80192 | |
| LRGVCLKEPNLCLVM | 206 | P80192 | |
| LKRALVSALCLMAPN | 1141 | Q9P2P1 | |
| IMNKRLRIQLVLGAC | 146 | P30954 | |
| MRCGQVLRAPKGQIL | 126 | Q6UXH9 | |
| RVSLMCPLGKMRLTI | 341 | O75928 | |
| SARKPLCNRVRMAAV | 206 | E9PJI5 | |
| SARKPLCNRVRMAAV | 206 | P0DM63 | |
| APNAKLRLMVLALGV | 86 | Q9H720 | |
| TLLRKVLCGDPVMRV | 901 | Q86VV8 | |
| RQRMLKAQLDLSVPC | 466 | Q9HCB6 | |
| HPRRCREVLMKTALG | 101 | Q8N4H0 | |
| MGNPRLPRLLCALKF | 1 | P59090 | |
| MAAALARLGLRPVKQ | 1 | Q96EL3 | |
| CRALIKRIQAMIPKG | 211 | P07988 | |
| MLPAGCSRRLVAELQ | 1 | Q7L2K0 | |
| SARKPLCNRVRMAAV | 206 | E9PKD4 | |
| ELCRPSKRRMQAVAN | 281 | Q8WUX1 | |
| KTLVIILNCMRSRNP | 831 | Q8IVG5 | |
| VGCPRILNTNLRQIM | 21 | Q9Y227 | |
| ILARSHGLLPKCIMQ | 1601 | Q8TCU6 | |
| KRPGDLSVRCTLLLM | 241 | Q6STE5 | |
| MRTKAAGCAERRPLQ | 1 | Q9UNP4 | |
| LVLLVRILCGSRKMP | 196 | Q96LA9 | |
| MAAQRPLRVLCLAGF | 1 | Q8WZ82 | |
| RLIPQALKIREMCNC | 451 | Q96E52 | |
| GTSLEALCRMKRPIR | 681 | Q01968 | |
| LPGLKRLCGRSLAQM | 361 | Q969K4 | |
| FRVCLLINKLLGSMP | 116 | Q9BPX3 | |
| RDPAIMGLRNILKVC | 446 | Q9NQ89 | |
| RGKPMCFVRSLLRVQ | 56 | G3V211 | |
| ELALPGCTSRMLKLL | 886 | Q6ZRI6 | |
| NTRGSARLLCAEMPK | 16 | Q8WUR7 | |
| CLPDLSIISMLKQRR | 66 | Q8N9Z0 | |
| RPRMKCQTATGLIAL | 171 | Q8TCW9 | |
| LRVSLMCPLGKMRLT | 321 | Q9Y6X2 | |
| RTCTAPLDRLKVLMQ | 201 | Q6KCM7 | |
| VRCSNKGLRALPRGM | 736 | O75094 | |
| LKILAIEMRFRCGIP | 2401 | Q63HN8 | |
| MRRQPAKVAALLLGL | 1 | Q96AW1 | |
| RLCALKGARPAMSRA | 1421 | Q13009 | |
| GIAKNRLELMPCVVL | 866 | Q96T58 | |
| LQCMAKPLSVRTLLF | 336 | Q9HC29 | |
| ARLLPTMCIQASEGK | 641 | Q9HC29 | |
| GGLILRMGAINRCLK | 146 | Q9ULX5 | |
| RMGAINRCLKHPLAR | 151 | Q9ULX5 | |
| KRPQARMLLLALFCV | 291 | Q8TCT7 | |
| VCLQRAPASKMLTLL | 256 | D6R901 | |
| TGPKDCLRSIMRRVN | 41 | Q92783 | |
| TAPQCLLRIKRDIMS | 96 | Q9H832 | |
| GMCSIRLSEPLLKLR | 86 | Q9H040 | |
| RSAKQCMLAIKEGRP | 91 | Q5TFG8 | |
| VCLQRAPASKMLTLL | 256 | C9JPN9 | |
| CKMVLLTRSENKAPR | 321 | Q96KM6 | |
| GIGCRRSMRLLKVDP | 211 | Q9H967 | |
| LRSLGRSLCPLVVKM | 26 | P0CG32 | |
| APRLRSAPNCILLAM | 76 | P18405 | |
| GLPAKRCVLRETNMA | 191 | P0C1S8 | |
| IKLFMNCRGRLSEAP | 996 | Q9NYU1 | |
| RPLEVFMCSVLKRQG | 171 | Q9Y6B6 | |
| SIGMLNSAPQLRCIK | 1431 | Q9Y4E6 | |
| TRVILRMLPISGTCK | 156 | Q9NXG2 | |
| SKRMGNACIPLKRIA | 6 | O95970 | |
| RGPAKMLLLLALACA | 11 | O15399 |